Global Cardiac Resynchronization Therapy - CRT
Market Report
2025
The Cardiac Resynchronization Therapy Market was valued at USD 6.52 Billion in 2022 at is expected to reach USD 11.58 Billion in 2030, registering a CAGR of 7.4% in the forecast period 2023-2030.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Cardiac Resynchronization Therapy - CRT Market Report 2025.
The Cardiac Resynchronization Therapy Market was valued at USD 6.52 Billion in 2022 at is expected to reach USD 11.58 Billion in 2030, registering a CAGR of 7.4% in the forecast period 2023-2030.
2024 | 2025 | 2032 | 2033 | CAGR | |
---|---|---|---|---|---|
Global Cardiac Resynchronization Therapy - CRT Market Sales Revenue | 121212 | 121212 | 121212 | 121212 | 7.4% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by Application |
|
Market Split by End use |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Cardiac Resynchronization Therapy - CRT industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Cardiac Resynchronization Therapy - CRT Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Cardiac resynchronization therapy known as CRT or biventricular pacing is used to treat heart patients. Patients with heart diseases such as arrhythmia, and heart failure need to undergo cardiac resynchronization therapy. In this treatment, the pacemaker is inserted below the collarbone to restore a normal heartbeat. In the treatment, the implantable biventricular pacemaker is used which generates and sends a signal to the right and left ventricles to pump the blood together and start the heartbeat rhythm regularly. The treatment has two types: cardiac resynchronization therapy defibrillator and cardiac resynchronization therapy pacemaker. The cardiac resynchronization therapy market is driven by an increase in the geriatric population and cardiac disorders in the aged population.
The growth in the geriatric population in the world, the inactive lifestyle of the population, and in adding the increase in the prevalence of cardiac diseases and heart failure patients are the factors that stimulate increment in the Cardiac Resynchronization Therapy Market. The aging population is increasing and the birth rate has come down across the globe. The increase in the prevalence of cardiac diseases and heart failure is due to the rise in the geriatric population. Thus, the demand for the cardiac resynchronization therapy market is augmenting because of growth in the geriatric population. In addition, unhealthy diet, diabetes, obesity, an inactive lifestyle, and alcohol addiction are the main reasons for heart disease to cause. The increasing number of heart illnesses globally, and the affected people are going under cardiac resynchronization therapy all over the world.
Additionally, the development in technology and modern healthcare equipment, in emerging countries is also the factor driving the growth of the cardiac resynchronization therapy market.
The premium cost of the products used in the therapy, is not affordable to some patients, even if they are in a serious situation. The expensive price of the products is one of the major restraining factors of market growth. The pacemaker’s average cost is around USD 6,250. After every three to seven years the pacemakers and defibrillators are needed to be changed. Many patients in underdeveloped and developing countries cannot afford cardiac resynchronization therapy because the countries don’t have the proper remuneration policies. Due to this, the expenditure in CRT increased in the forecast period.
Additionally, cardiac resynchronization therapy has a risk factor with surgical site infection, as it is invasive and this is one more hurdle or challenge for the market growth. while avoiding certain risks because its lead is placed outside the heart and veins.
The outbreak of COVID-19 has witnessed a significant impact on the cardiac resynchronization therapy market. The government rules and guidelines for lockdown affected the import and export of raw materials and stopped production and affected the supply chain distribution of the market. Additionally, cardiac treatment got delayed due to the lockdown, and clinical trials delay.
We have various report editions of Cardiac Resynchronization Therapy - CRT Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Abbott announced its complete acquisition of Cardiovascular System Inc, (CSI), a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. Lissa Earnhardt, executive vice president, of Medical Devices, Abbott, said “The acquisition of CSI is a component of an overall investment in our vascular portfolio that enhances our ability to care for patients with peripheral and coronary artery disease.
Medtronic plc has received the mark for the Aurora EV-ICD MRI sure scan Extravascular Implantable Cardioverter-Defibrillator. The Defibrillator leads to treating dangerously fast heart rhythms that can lead to sudden cardiac arrest. The Aurora EV-ICD system provides the life-saving benefits of traditional ICDs
The major market players focus on innovation, acquisition, and advanced technology. For instance, Abbott Laboratories announced the acquisition of Cardiovascular System Inc. Additionally, technological advancement by Abbott Laboratories, as new data show remote monitoring technology like Abbott cardio-mems helps improve survival in heart failure patients.
Top Companies Market Share in Cardiac Resynchronization Therapy - CRT Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Asia-Pacific is expected to dominate the market in the upcoming period, due to the rising geriatric population in Japan according to Statista the Japanese have 65% of the geriatric population. Additionally, developing medical infrastructure in India, and increased cardiovascular disease incidence are the factors driving the segment growth in the market.
The current report Scope analyzes Cardiac Resynchronization Therapy - CRT Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Cardiac Resynchronization Therapy - CRT Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Cardiac Resynchronization Therapy - CRT Industry growth. Cardiac Resynchronization Therapy - CRT market has been segmented with the help of its Type, Application End use, and others. Cardiac Resynchronization Therapy - CRT market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
The cardiac resynchronization therapy defibrillators segment is expected to show the highest CAGR in the market in the upcoming period. Further, the Cardiac Resynchronization Therapy Pacemaker is anticipated to dominate the market in the upcoming period due to the growth in the geriatric population globally, and the increase in cardiac diseases worldwide is augmenting the growth of the segment in the market. In addition, many professionals are advising the cardiac resynchronization therapy pacemaker to heart failure patients.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Cardiac Resynchronization Therapy - CRT Industry. Request a Free Sample PDF!
This report analyzes revenue growth in the {Keyword} market across global, regional, and national levels, highlighting trends and opportunities for each application. It examines how sectors like diagnostics, therapy, and monitoring utilize devices to meet healthcare needs. Key factors include market size, revenue contributions, technological innovations (e.g., AI diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. (For more information, please request a sample or contact our research team)
Some of the key Application of Cardiac Resynchronization Therapy - CRT are:
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
The hospital segment is expected to highest growth rate in the market, due to the increasing number of cardiovascular diseases, the rising number of surgeries performed in the hospitals, the availability of all facilities to the patient, and well-skilled professionals are available. In addition, cardiac centers are projected to show growth in the market, due to the rising number of cardiac specialty clinics, critical care is the aspect that is intended to grow the segment in the forecast period.
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Cardiac Resynchronization Therapy - CRT Market is witnessing significant growth in the near future.
In 2023, the Cardiac Resynchronization Therapy Defibrillators segment accounted for noticeable share of global Cardiac Resynchronization Therapy - CRT Market and is projected to experience significant growth in the near future.
The Hospitals segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Medtronic , Abbott Laboratories and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Cardiac Resynchronization Therapy Defibrillators, Cardiac Resynchronization Therapy Pacemaker |
Application | Hospitals, Home Health Care, Ambulatory Services, Others |
End use | Hospitals, Cardiac Centers, Ambulatory Surgery Centers |
List of Competitors | Medtronic, PLC, Abbott Laboratories, Lepu Medical Technology Co, Boston Scientific Corporation, Biotronik, Medico S.P.A., Shree Pacetronix Ltd, Microport Scientific Corporation |
This chapter will help you gain GLOBAL Market Analysis of Cardiac Resynchronization Therapy - CRT. Further deep in this chapter, you will be able to review Global Cardiac Resynchronization Therapy - CRT Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Cardiac Resynchronization Therapy - CRT. Further deep in this chapter, you will be able to review North America Cardiac Resynchronization Therapy - CRT Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Cardiac Resynchronization Therapy - CRT. Further deep in this chapter, you will be able to review Europe Cardiac Resynchronization Therapy - CRT Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Cardiac Resynchronization Therapy - CRT. Further deep in this chapter, you will be able to review Asia Pacific Cardiac Resynchronization Therapy - CRT Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Cardiac Resynchronization Therapy - CRT. Further deep in this chapter, you will be able to review South America Cardiac Resynchronization Therapy - CRT Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Cardiac Resynchronization Therapy - CRT. Further deep in this chapter, you will be able to review Middle East Cardiac Resynchronization Therapy - CRT Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Cardiac Resynchronization Therapy - CRT. Further deep in this chapter, you will be able to review Middle East Cardiac Resynchronization Therapy - CRT Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Cardiac Resynchronization Therapy - CRT. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by End use Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Cardiac Resynchronization Therapy - CRT market
Chapter 13 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 14 Research Methodology and Sources
Why Cardiac Resynchronization Therapy Defibrillators have a significant impact on Cardiac Resynchronization Therapy - CRT market? |
What are the key factors affecting the Cardiac Resynchronization Therapy Defibrillators and Cardiac Resynchronization Therapy Pacemaker of Cardiac Resynchronization Therapy - CRT Market? |
What is the CAGR/Growth Rate of Hospitals during the forecast period? |
By type, which segment accounted for largest share of the global Cardiac Resynchronization Therapy - CRT Market? |
Which region is expected to dominate the global Cardiac Resynchronization Therapy - CRT Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|